HLA Typing for Transplant Market by Technology, Product, Application, Type, End User - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Secondary Sources
2.1.1.2 Key Objectives of Secondary Research
2.1.2 Primary Data
2.1.2.1 Key Primary Sources
2.1.2.2 Key Objectives of Primary Research
2.1.2.3 Key Insights from Primary Experts
2.1.2.4 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Market Estimation Approach
2.2.1.1 Company Revenue-based Market Estimation Approach Top-Down Approach
2.2.1.2 Procedure-based Market Estimation Bottom-Up Approach
2.2.1.3 Growth Forecast
2.2.1.4 CAGR Projections
2.3 Data Triangulation
2.4 Market Share Estimation
2.5 Study Assumptions
2.5.1 Market Assumptions
2.5.2 Growth Rate Assumptions
2.6 Risk Analysis
2.7 Research Limitations

4.1 Hla Typing for Transplant Market Overview
4.2 North America: Hla Typing for Transplant Market, by Product & Service and Country, 2024
4.3 Hla Typing for Transplant Market: Emerging vs. Developed Markets, 2025 vs. 2030 (USD Million)
4.4 Hla Typing for Transplant Market: Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Number of Organ Donors and Transplant Procedures
5.2.1.2 Surge in Organ Failure Cases due to Increased Prevalence of Chronic Diseases
5.2.1.3 Increasing Research Activities and Rising Funding for Organ Transplantations
5.2.1.4 Growing Adoption of Hla Typing in Personalized Medicines
5.2.2 Restraints
5.2.2.1 High Costs of Hla Typing Products
5.2.2.2 Shortage of Healthy Organs for Transplants
5.2.3 Opportunities
5.2.3.1 Adoption of Ngs and Automation for High-Throughput Needs
5.2.3.2 Use of AI and ML in Hla Typing for Better Accuracy and Broader Clinical Utility
5.2.4 Challenges
5.2.4.1 Regulatory Complexities Across Regions
5.2.4.2 Lack of Standardization Across Hla Typing Laboratories
5.3 Regulatory Analysis
5.3.1 Regulatory Framework
5.3.1.1 North America
5.3.1.1.1 US
5.3.1.1.2 Canada
5.3.1.2 Europe
5.3.1.2.1 UK
5.3.1.2.2 France
5.3.1.2.3 Germany
5.3.1.3 Asia-Pacific
5.3.1.3.1 China
5.3.1.3.2 Japan
5.3.1.3.3 India
5.3.1.4 Latin America
5.3.1.4.1 Brazil
5.3.1.4.2 Mexico
5.3.1.5 Middle East & Africa
5.3.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.4 Value Chain Analysis
5.4.1 Research & Development
5.4.2 Raw Material Procurement & Product Development
5.4.3 Marketing, Sales, and Distribution, and Aftermarket Service
5.5 Supply Chain Analysis
5.5.1 Prominent Companies
5.5.2 Small and Medium-Sized Enterprises
5.5.3 Sales & Distribution Agents
5.5.4 End-users
5.6 Ecosystem Analysis
5.6.1 Role in Ecosystem
5.7 Trade Analysis
5.7.1 Import Scenario for HS Code 3822, 2020-2024
5.7.2 Export Scenario for HS Code 3822, 2020-2024
5.8 Patent Analysis
5.8.1 List of Major Patents/Patent Applications
5.9 Pricing Analysis
5.9.1 Average Selling Pricing Trend of Instruments, by Type, 2023-2024
5.9.2 Average Selling Pricing Trend of Next-Generation Sequencing Instruments, by Key Player, 2023-2024
5.9.3 Average Selling Pricing Trend of Reagents, by Type, 2022-2024
5.10 Technology Analysis
5.10.1 Key Technologies
5.10.1.1 Next-Generation Sequencing
5.10.1.2 Pcr-Sequence-Specific Oligonucleotide Probes
5.10.2 Complementary Technologies
5.10.2.1 Single Antigen-based Assays
5.10.2.2 Flow Cytometry Crossmatch
5.10.3 Adjacent Technologies
5.10.3.1 Bioinformatics Software
5.11 Porter's Five Force Analysis
5.11.1 Threat of New Entrants
5.11.2 Threat of Substitutes
5.11.3 Bargaining Power of Suppliers
5.11.4 Bargaining Power of Buyers
5.11.5 Intensity of Competitive Rivalry
5.12 Key Stakeholders & Buying Criteria
5.12.1 Key Stakeholders in Buying Process
5.12.2 Key Buying Criteria
5.13 Key Conferences & Events in 2024-2025
5.14 Case Study Analysis
5.14.1 Thermo Fisher Scientific to Develop Techniques for Enhancing Hla Typing Accuracy in Transplantation
5.14.2 Illumina to Streamline Hla Typing with Trusight Hla Solution
5.14.3 Werfen to Accelerate Hla Typing with Nanopore Sequencing
5.15 Trends/Disruptions Impacting Customers’ Businesses
5.16 Investment & Funding Scenario
5.17 Unmet Needs
5.18 Impact of AI/Gen AI on Hla Typing for Transplant Market
5.18.1 Market Potential of Hla Typing Products for Pre-Transplant Evaluation
5.18.1.1 AI Use Cases in Hla Typing for Transplant Market
5.18.1.2 Key Companies Implementing AI
5.18.2 Future of AI in Hla Typing for Transplant Market
5.19 Impact of 2025 US Tariff on Hla Typing for Transplant Market
5.19.1 Introduction
5.19.2 Key Tariff Rates
5.19.3 Price Impact Analysis
5.19.4 Impact on Country/Region
5.19.4.1 North America
5.19.4.1.1 US
5.19.4.2 Europe
5.19.4.3 Asia-Pacific
5.19.5 Impact on End-use Industries

6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Availability of Multiple Varieties of Reagents & Consumables to Drive Adoption in Hla Typing Phases
6.3 Instruments
6.3.1 Need for Precise and Reliable Hla Matching in Bone Marrow and Organ Transplants to Propel Market Growth
6.4 Software & Services
6.4.1 Growing Automation and Digitalization of Diagnostic Laboratory Procedures to Aid Market Growth

7.1 Introduction
7.2 Molecular Assays
7.2.1 Pcr-based Molecular Assays
7.2.1.1 Sequence-Specific Primer-Pcr
7.2.1.1.1 Cost-Effectiveness and High Accuracy to Drive Identification of Hla Variants at Low to Intermediate Resolutions
7.2.1.2 Sequence-Specific Oligonucleotide-Pcr
7.2.1.2.1 Development and Commercialization of Innovative Sequence-Specific Oligonucleotide-Pcr Products to Aid Segment Growth
7.2.1.3 Real-Time Pcr
7.2.1.3.1 High Sensitivity, Effective Real-Time DNA Amplification Monitoring, and Minimal Sample Need to Drive Segment
7.2.1.4 Other Pcr-based Molecular Assays
7.3 Sequencing-based Molecular Assays
7.3.1 Sanger Sequencing
7.3.1.1 High Accuracy and Single-Base Resolution to Detect Allelic Variants and Confirm Novel or Rare Alleles
7.3.2 Next-Generation Sequencing
7.3.2.1 Growing Reliance on Outsourcing In-House Analysis to Propel Demand in Tissue Typing
7.3.3 Other Sequencing-based Molecular Assays
7.4 Non-Molecular Assays
7.4.1 Lower Costs and Higher Specificity to Drive Adoption Over Molecular Assays

8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Antibody Screening
8.2.1.1 Advancement in Pre-Transplant Compatibility Screening with Ngs to Aid Segment Growth
8.2.2 Chimerism Monitoring
8.2.2.1 Growing Trend of Personalized Transplant Medicine for Effective Post-Procedural Clinical Risk Management to Fuel Adoption
8.2.3 Other Diagnostic Applications
8.3 Research Applications
8.3.1 Increasing Public-Private Investments for Transplant Diagnostics Research to Favor Market Growth

9.1 Introduction
9.2 Solid Organ Transplants
9.2.1 High Popularity of Organ Donation and Favorable Government Initiatives to Drive Market
9.3 Soft-Tissue Transplants
9.3.1 Need for Hla Typing in Composite Tissue Allotransplantation to Aid Adoption
9.4 Stem Cell Transplants
9.4.1 Expanding Diversity of Donor Registries to Fuel Adoption of Hla Typing

10.1 Introduction
10.2 Independent Reference Laboratories
10.2.1 Adherence to Quality and Regulatory Standards with High-Quality Services to Drive Market Growth
10.3 Hospitals & Transplant Centers
10.3.1 Developed Healthcare Infrastructure and High Success Rates in Transplant Procedures to Drive Market
10.4 Research Laboratories & Academic Institutes
10.4.1 Increasing Collaborations to Develop and Optimize Hla Typing for Better Accuracy, Specificity, and Efficiency

11.1 Introduction
11.2 North America
11.2.1 Macroeconomic Outlook for North America
11.2.2 US
11.2.2.1 US to Dominate Hla Typing for Transplant Market During Forecast Period
11.2.3 Canada
11.2.3.1 Rising Number of Solid Organ and Hematopoietic Stem Cell Transplants to Drive Market Adoption of Hla Typing
11.3 Europe
11.3.1 Macroeconomic Outlook for Europe
11.3.2 Germany
11.3.2.1 High Donor Registration Rates and Favorable Government Initiatives to Augment Market Growth
11.3.3 UK
11.3.3.1 Strong Healthcare Infrastructure and Centrally Coordinated Transplant System to Foster Growth
11.3.4 France
11.3.4.1 Growing Adoption for Donor-Recipient Compatibility Testing to Support Market
11.3.5 Spain
11.3.5.1 Increasing Popularity of Solid Organ Donation to Drive Market
11.3.6 Italy
11.3.6.1 Supportive Government Policies and Strong Healthcare Infrastructure to Spur Market Growth
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Macroeconomic Outlook for Asia-Pacific
11.4.2 China
11.4.2.1 Presence of Leading Global Manufacturers of Hla Typing Products to Drive Market
11.4.3 India
11.4.3.1 Rise in Transplantation Procedures and Use of Hla Typing for Assessing Donor-Recipient Compatibility to Spur Market Growth
11.4.4 Japan
11.4.4.1 Increasing Number of Solid Organ Transplantation Procedures and Rising Chronic Diseases to Favor Market Growth
11.4.5 Australia
11.4.5.1 Increasing Use of Genomic Testing and Analysis and Growing Government Backing for Clinical Diagnostics to Drive Market
11.4.6 South Korea
11.4.6.1 Government Support and Advanced Healthcare to Drive Adoption of Ngs Hla Typing for Better Transplant Outcomes
11.4.7 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Macroeconomic Outlook for Latin America
11.5.2 Brazil
11.5.2.1 Growing Elderly Demographic and Increasing Funding from Leading Hla Typing Manufacturers to Propel Market Growth
11.5.3 Mexico
11.5.3.1 Wide Recipient Base for Organ Transplant and Rise in Medical Tourism to Fuel Market Growth
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Macroeconomic Outlook for Middle East & Africa
11.6.2 GCC Countries
11.6.2.1 Improvements in Healthcare Infrastructure and Focus on Specialized Medical Services to Augment Market Growth
11.6.3 Rest of Middle East & Africa

12.1 Introduction
12.2 Key Player Strategy/Right to Win
12.2.1 Overview of Strategies Adopted by Players in Hla Typing for Transplant Market
12.3 Revenue Analysis, 2020-2024
12.4 Market Share Analysis, 2024
12.5 Company Evaluation Matrix: Key Players, 2024
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2024
12.5.5.1 Company Footprint
12.5.5.2 Region Footprint
12.5.5.3 Product & Service Footprint
12.5.5.4 Technology Footprint
12.5.5.5 Application Footprint
12.5.5.6 End-user Footprint
12.6 Company Evaluation Matrix: Startups/SMEs, 2024
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Company Benchmarking: Startups/SMEs, 2024
12.6.5.1 Detailed List of Key Startups/SMEs
12.6.5.2 Competitive Benchmarking of Key Startups/SMEs
12.7 Company Valuation & Financial Metrics
12.7.1 Financial Metrics
12.7.2 Company Valuation
12.8 Brand/Product Comparison
12.9 Competitive Scenario
12.9.1 Product Launches and Approvals
12.9.2 Deals

13.1 Major Players
13.1.1 Thermo Fisher Scientific Inc.
13.1.1.1 Business Overview
13.1.1.2 Products/Services/Solutions Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product Approvals
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 Analyst's View
13.1.1.4.1 Key Strengths
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses & Competitive Threats
13.1.2 Illumina, Inc.
13.1.2.1 Business Overview
13.1.2.2 Products/Services/Solutions Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Expansions
13.1.2.4 Analyst's View
13.1.2.4.1 Key Strengths
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses & Competitive Threats
13.1.3 Qiagen
13.1.3.1 Business Overview
13.1.3.2 Products/Services/Solutions Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product Launches
13.1.3.3.2 Deals
13.1.3.4 Analyst's View
13.1.3.4.1 Key Strengths
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses & Competitive Threats
13.1.4 Bio-Rad Laboratories, Inc.
13.1.4.1 Business Overview
13.1.4.2 Products/Services/Solutions Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Product Launches
13.1.4.4 Analyst's View
13.1.4.4.1 Key Strengths
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses & Competitive Threats
13.1.5 F. Hoffmann-La Roche Ltd.
13.1.5.1 Business Overview
13.1.5.2 Products/Services/Solutions Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Expansions
13.1.5.4 Analyst's View
13.1.5.4.1 Key Strengths
13.1.5.4.2 Strategic Choices
13.1.5.4.3 Weaknesses & Competitive Threats
13.1.6 Caredx, Inc.
13.1.6.1 Business Overview
13.1.6.2 Products/Services/Solutions Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product Launches and Approvals
13.1.6.3.2 Deals
13.1.7 Werfen
13.1.7.1 Business Overview
13.1.7.2 Products/Services/Solutions Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Product Launches
13.1.7.3.2 Deals
13.1.8 Diasorin S.P.A.
13.1.8.1 Business Overview
13.1.8.2 Products/Services/Solutions Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Product Approvals
13.1.9 Tbg Biotechnology Corp.
13.1.9.1 Business Overview
13.1.9.2 Products/Services/Solutions Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product Approvals
13.1.9.3.2 Deals
13.1.10 Fujirebio
13.1.10.1 Business Overview
13.1.10.2 Products/Services/Solutions Offered
13.1.10.3 Recent Developments
13.1.10.3.1 Deals
13.1.11 Becton, Dickinson and Company
13.1.11.1 Business Overview
13.1.11.2 Products/Services/Solutions Offered
13.1.12 Eurobio Scientific
13.1.12.1 Business Overview
13.1.12.2 Products/Services/Solutions Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Product Launches and Approvals
13.1.12.3.2 Deals
13.1.13 Pacbio
13.1.13.1 Business Overview
13.1.13.2 Products/Services/Solutions Offered
13.1.13.3 Recent Developments
13.1.13.3.1 Product Approvals and Updates
13.1.13.3.2 Deals
13.1.14 Bag Diagnostics GmbH
13.1.14.1 Business Overview
13.1.14.2 Products/Services/Solutions Offered
13.1.15 Creative Biolabs
13.1.15.1 Business Overview
13.1.15.2 Products/Services/Solutions Offered
13.2 Other Players
13.2.1 Histogenetics LLC
13.2.2 Scisco Genetics, Inc.
13.2.3 Inno-Train Diagnostik GmbH
13.2.4 Bionobis
13.2.5 Takara Bio Inc.
13.2.6 Krishgen Biosystems
13.2.7 Sciencell Research Laboratories, Inc.
13.2.8 Proimmune Ltd.
13.2.9 Alpha Biotech Limited
13.2.10 Biofortuna Limited

14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options

Table 1 Hla Typing for Transplant Market: Inclusions & Exclusions
Table 2 Hla Typing for Transplant Market Assumptions
Table 3 Hla Typing for Transplant Market: Risk Analysis
Table 4 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 5 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 6 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 Hla Typing Market: Role in Ecosystem
Table 9 Hla Typing for Transplant Market: Import Scenario for HS Code 3822, by Country, 2020-2024 (USD Thousand)
Table 10 Hla Typing for Transplant Market: Export Scenario for HS Code 3822, by Country, 2020-2024 (USD Thousand)
Table 11 Hla Typing for Transplant Market: List of Major Patents/ Patent Applications
Table 12 Average Selling Pricing Trend of Next-Generation Sequencing Instruments, by Key Player, 2023-2024 (USD)
Table 13 Average Selling Pricing Trend of Instruments and Reagents, by Region, 2022-2024 (USD Thousand)
Table 14 Hla Typing for Transplant Market: Porters Five Forces
Table 15 Influence of Key Stakeholders on Buying Process, by Product & Service (%)
Table 16 Influence of Key Stakeholders on Buying Process for Major End-users
Table 17 Hla Typing for Transplant Market: List of Key Conferences & Events, January 2025-December 2026
Table 18 Thermo Fisher Scientific to Develop Techniques for Enhancing Hla Typing Accuracy in Transplantation
Table 19 Illumina to Streamline Hla Typing with Trusight Hla Solution
Table 20 Werfen to Accelerate Hla Typing with Nanopore Sequencing
Table 21 Hla Typing for Transplant Market: Unmet Needs
Table 22 Hla Typing for Transplant Market: Key Companies Implementing AI
Table 23 US Adjusted Reciprocal Tariff Rates
Table 24 Hla Typing for Transplant Market, by Product & Service, 2023-2030 (USD Million)
Table 25 Hla Typing for Transplant Market for Reagents & Consumables, by Region, 2023-2030 (USD Million)
Table 26 Hla Typing for Transplant Market for Instruments, by Region, 2023-2030 (USD Million)
Table 27 Hla Typing for Transplant Market for Software & Services, by Region, 2023-2030 (USD Million)
Table 28 Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 29 Hla Typing for Transplant Technology Market, by Region, 2023-2030 (USD Million)
Table 30 Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 31 Hla Typing for Transplant Market for Molecular Assays, by Region, 2023-2030 (USD Million)
Table 32 Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 33 Pcr-based Molecular Assays Market, by Region, 2023-2030 (USD Million)
Table 34 Sequence-Specific Primer-Pcr Market, by Region, 2023-2030 (USD Million)
Table 35 Sequence-Specific Oligonucleotide-Pcr Market, by Region, 2023-2030 (USD Million)
Table 36 Real-Time Pcr Market, by Region, 2023-2030 (USD Million)
Table 37 Other Pcr-based Molecular Assays Market, by Region, 2023-2030 (USD Million)
Table 38 Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 39 Sequencing-based Molecular Assays Market, by Region, 2023-2030 (USD Million)
Table 40 Sanger Sequencing Market, by Region, 2023-2030 (USD Million)
Table 41 Next-Generation Sequencing Market, by Region, 2023-2030 (USD Million)
Table 42 Other Sequencing-based Molecular Assays Market, by Region, 2023-2030 (USD Million)
Table 43 Hla Typing for Transplant Market for Non-Molecular Assays, by Region, 2023-2030 (USD Million)
Table 44 Hla Typing for Transplant Market, by Application, 2023-2030 (USD Million)
Table 45 Hla Typing for Transplant Market for Diagnostic Applications, by Type, 2023-2030 (USD Million)
Table 46 Hla Typing for Transplant Market for Diagnostic Applications, by Region, 2023-2030 (USD Million)
Table 47 Antibody Screening Market, by Region, 2023-2030 (USD Million)
Table 48 Chimerism Monitoring Market, by Region, 2023-2030 (USD Million)
Table 49 Other Diagnostic Applications Market, by Region, 2023-2030 (USD Million)
Table 50 Hla Typing for Transplant Market for Research Applications, by Region, 2023-2030 (USD Million)
Table 51 Hla Typing for Transplant Market, by Transplant Type, 2023-2030 (USD Million)
Table 52 Hla Typing for Solid Organ Transplants Market, by Region, 2023-2030 (USD Million)
Table 53 Hla Typing for Soft-Tissue Transplants Market, by Region, 2023-2030 (USD Million)
Table 54 Hla Typing for Stem Cell Transplants Market, by Region, 2023-2030 (USD Million)
Table 55 Hla Typing for Transplant Market, by End-user, 2023-2030 (USD Million)
Table 56 Hla Typing for Transplant Market for Independent Reference Laboratories, 2023-2030 (USD Million)
Table 57 Hla Typing for Transplant Market for Hospitals & Transplant Centers, 2023-2030 (USD Million)
Table 58 Hla Typing for Transplant Market for Research Laboratories & Academic Institutes, 2023-2030 (USD Million)
Table 59 Hla Typing for Transplant Market, by Region, 2023-2030 (USD Million)
Table 60 Hla Typing for Transplant Market: Transplant Volume by Type, 2023 (Number of Transplants)
Table 61 North America: Key Macroindicators
Table 62 North America: Hla Typing for Transplant Market, by Country, 2023-2030 (USD Million)
Table 63 North America: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 64 North America: Hla Typing for Transplant Market, by Product & Service, 2023-2030 (USD Million)
Table 65 North America: Hla Typing for Transplant Market, by End-user, 2023-2030 (USD Million)
Table 66 US: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 67 US: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 68 US: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 69 US: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 70 Canada: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 71 Canada: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 72 Canada: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 73 Canada: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 74 Europe: Key Macroindicators
Table 75 Europe: Hla Typing for Transplant Market, by Country, 2023-2030 (USD Million)
Table 76 Europe: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 77 Europe: Hla Typing for Transplant Market, by Product & Service, 2023-2030 (USD Million)
Table 78 Europe: Hla Typing for Transplant Market, by End-user, 2023-2030 (USD Million)
Table 79 Germany: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 80 Germany: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 81 Germany: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 82 Germany: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 83 UK: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 84 UK: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 85 UK: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 86 UK: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 87 France: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 88 France: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 89 France: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 90 France: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 91 Spain: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 92 Spain: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 93 Spain: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 94 Spain: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 95 Italy: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 96 Italy: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 97 Italy: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 98 Italy: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 99 Rest of Europe: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 100 Rest of Europe: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 101 Rest of Europe: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 102 Rest of Europe: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 103 Asia-Pacific: Key Macroindicators
Table 104 Asia-Pacific: Hla Typing for Transplant Market, by Country, 2023-2030 (USD Million)
Table 105 Asia-Pacific: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 106 Asia-Pacific: Hla Typing for Transplant Market, by Product & Service, 2023-2030 (USD Million)
Table 107 Asia-Pacific: Hla Typing for Transplant Market, by End-user, 2023-2030 (USD Million)
Table 108 China: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 109 China: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 110 China: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 111 China: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 112 India: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 113 India: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 114 India: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 115 India: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 116 Japan: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 117 Japan: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 118 Japan: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 119 Japan: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 120 Australia: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 121 Australia: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 122 Australia: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 123 Australia: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 124 South Korea: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 125 South Korea: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 126 South Korea: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 127 South Korea: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 128 Rest of Asia-Pacific: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 129 Rest of Asia-Pacific: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 130 Rest of Asia-Pacific: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 131 Rest of Asia-Pacific: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 132 Latin America: Key Macroindicators
Table 133 Latin America: Hla Typing for Transplant Market, by Country, 2023-2030 (USD Million)
Table 134 Latin America: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 135 Latin America: Hla Typing for Transplant Market, by Product & Service, 2023-2030 (USD Million)
Table 136 Latin America: Hla Typing for Transplant Market, by End-user, 2023-2030 (USD Million)
Table 137 Brazil: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 138 Brazil: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 139 Brazil: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 140 Brazil: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 141 Mexico: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 142 Mexico: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 143 Mexico: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 144 Mexico: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 145 Rest of Latin America: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 146 Rest of Latin America: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 147 Rest of Latin America: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 148 Rest of Latin America: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 149 Middle East & Africa: Key Macroindicators
Table 150 Middle East & Africa: Hla Typing for Transplant Market, by Region, 2023-2030 (USD Million)
Table 151 Middle East & Africa: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 152 Middle East & Africa: Hla Typing for Transplant Market, by Product & Service, 2023-2030 (USD Million)
Table 153 Middle East & Africa: Hla Typing for Transplant Market, by End-user, 2023-2030 (USD Million)
Table 154 GCC Countries: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 155 GCC Countries: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 156 GCC Countries: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 157 GCC Countries: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 158 Rest of Middle East & Africa: Hla Typing for Transplant Market, by Technology, 2023-2030 (USD Million)
Table 159 Rest of Middle East & Africa: Hla Typing for Transplant Market for Molecular Assays, by Type, 2023-2030 (USD Million)
Table 160 Rest of Middle East & Africa: Pcr-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 161 Rest of Middle East & Africa: Sequencing-based Molecular Assays Market, by Type, 2023-2030 (USD Million)
Table 162 Overview of Strategies Deployed by Key Companies in Hla Typing for Transplant Market
Table 163 Hla Typing for Transplant Market: Degree of Competition
Table 164 Hla Typing for Transplant Market: Region Footprint
Table 165 Hla Typing for Transplant Market: Product & Service Footprint
Table 166 Hla Typing for Transplant Market: Technology Footprint
Table 167 Hla Typing for Transplant Market: Application Footprint
Table 168 Hla Typing for Transplant Market: End-user Footprint
Table 169 Hla Typing for Transplant Market: Detailed List of Key Startups/SME Players
Table 170 Hla Typing for Transplant Market: Competitive Benchmarking of Key Startups/SME Players, by Product & Service and Region
Table 171 Hla Typing for Transplant Market: Product Launches and Approvals, January 2022-April 2025
Table 172 Hla Typing for Transplant Market: Deals, January 2022-April 2025
Table 173 Thermo Fisher Scientific Inc.: Company Overview
Table 174 Thermo Fisher Scientific Inc.: Products/Services/Solutions Offered
Table 175 Thermo Fisher Scientific Inc.: Product Approvals, January 2022-April 2025
Table 176 Thermo Fisher Scientific Inc.: Deals, January 2022-April 2025
Table 177 Thermo Fisher Scientific Inc.: Expansions, January 2022-April 2025
Table 178 Illumina, Inc.: Company Overview
Table 179 Illumina, Inc.: Products/Services/Solutions Offered
Table 180 Illumina, Inc.: Expansions, January 2022-April 2025
Table 181 Qiagen: Company Overview
Table 182 Qiagen: Products/Services/Solutions Offered
Table 183 Qiagen: Product Launches, January 2022-April 2025
Table 184 Qiagen: Deals, January 2022-April 2025
Table 185 Bio-Rad Laboratories, Inc.: Company Overview
Table 186 Bio-Rad Laboratories, Inc.: Products/Services/Solutions Offered
Table 187 Bio-Rad Laboratories, Inc.: Product Launches, January 2022-April 2025
Table 188 F. Hoffmann-La Roche Ltd.: Company Overview
Table 189 F. Hoffmann-La Roche Ltd.: Products/Services/Solutions Offered
Table 190 F. Hoffmann-La Roche Ltd.: Expansions, January 2022-April 2025
Table 191 Caredx, Inc.: Company Overview
Table 192 Caredx, Inc.: Products/Services/Solutions Offered
Table 193 Caredx, Inc.: Product Launches and Approvals, January 2022-April 2025
Table 194 Caredx, Inc.: Deals, January 2022-April 2025
Table 195 Werfen: Company Overview
Table 196 Werfen: Products/Services/Solutions Offered
Table 197 Werfen: Product Launches, January 2022-April 2025
Table 198 Werfen: Deals, January 2022-April 2025
Table 199 Diasorin S.P.A.: Company Overview
Table 200 Diasorin S.P.A.: Products/Services/Solutions Offered
Table 201 Diasorin S.P.A.: Product Approvals, January 2022-April 2025
Table 202 Tbg Biotechnology Corp.: Company Overview
Table 203 Tbg Biotechnology Corp.: Products/Services/Solutions Offered
Table 204 Tbg Biotechnology Corp.: Product Approvals, January 2022-April 2025
Table 205 Tbg Biotechnology Corp.: Deals, January 2022-April 2025
Table 206 Fujirebio: Company Overview
Table 207 Fujirebio: Products/Services/Solutions Offered
Table 208 Fujirebio: Deals, January 2022-April 2025
Table 209 Becton, Dickinson and Company: Company Overview
Table 210 Becton, Dickinson and Company: Products/Services/Solutions Offered
Table 211 Eurobio Scientific: Company Overview
Table 212 Eurobio Scientific: Products/Services/Solutions Offered
Table 213 Eurobio Scientific: Product Launches and Approvals, January 2022-April 2025
Table 214 Eurobio Scientific: Deals, January 2022-April 2025
Table 215 Pacbio: Company Overview
Table 216 Pacbio: Products/Services/Solutions Offered
Table 217 Pacbio: Product Approvals and Updates, January 2022-April 2025
Table 218 Pacbio: Deals, January 2022-April 2025
Table 219 Bag Diagnostics GmbH: Company Overview
Table 220 Bag Diagnostics GmbH: Products/Services/Solutions Offered
Table 221 Creative Biolabs: Company Overview
Table 222 Creative Biolabs: Products/Services/Solutions Offered
Table 223 Histogenetics LLC: Company Overview
Table 224 Scisco Genetics, Inc.: Company Overview
Table 225 Inno-Train Diagnostik GmbH: Company Overview
Table 226 Bionobis: Company Overview
Table 227 Takara Bio Inc.: Company Overview
Table 228 Krishgen Biosystems: Company Overview
Table 229 Sciencell Research Laboratories, Inc.: Company Overview
Table 230 Proimmune Ltd.: Company Overview
Table 231 Alpha Biotech Limited: Company Overview
Table 232 Biofortuna Limited: Company Overview

Figure 1 Hla Typing for Transplant Market Segmentation & Regional Scope
Figure 2 Hla Typing for Transplant Market: Years Considered
Figure 3 Hla Typing for Transplant Market: Research Design
Figure 4 Hla Typing for Transplant Market: Key Primary Sources
Figure 5 Hla Typing for Transplant Market: Key Insights from Primaries
Figure 6 Breakdown of Primary Interviews: Supply- and Demand-Side Participants
Figure 7 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 8 Research Methodology: Hypothesis Building
Figure 9 Market Size Estimation for Hla Typing for Transplant Market: Company Revenue Estimation
Figure 10 Revenue Share Analysis: Illustrative Example of Thermo Fisher Scientific Inc. (2024)
Figure 11 Hla Typing for Transplant Market: Company Revenue- and Procedure-based Market Estimation Approach
Figure 12 CAGR Projections: Supply-Side Analysis
Figure 13 Hla Typing for Transplant Market: Data Triangulation
Figure 14 Hla Typing for Transplant Market, by Product & Service, 2025 vs. 2030 (USD Million)
Figure 15 Hla Typing for Transplant Market, by Technology, 2025 vs. 2030 (USD Million)
Figure 16 Hla Typing for Transplant Market, by End-user, 2025 vs. 2030 (USD Million)
Figure 17 Hla Typing for Transplant Market: Regional Snapshot
Figure 18 Improved Healthcare Infrastructure and Favorable Government Initiatives to Drive Market
Figure 19 US and Reagents & Consumables Segment Accounted for Largest Market Share in 2024
Figure 20 Emerging Markets to Register Higher Growth Rates During Study Period
Figure 21 China to Register Highest CAGR from 2025 to 2030
Figure 22 Hla Typing for Transplant Market: Drivers, Restraints, Opportunities, and Challenges
Figure 23 Hla Typing for Transplant Market: Value Chain Analysis
Figure 24 Hla Typing for Transplant Market: Supply Chain Analysis
Figure 25 Hla Typing for Transplant Market: Ecosystem Analysis
Figure 26 Hla Typing for Transplant Market: Import Scenario for HS Code 3822 (2020-2024)
Figure 27 Hla Typing for Transplant Market: Import Scenario for HS Code 3822 (2020-2024)
Figure 28 Hla Typing for Transplant Market: Top Patent Applicants/ Owners (January 2014-December 2025)
Figure 29 Average Selling Pricing Trend of Instruments, by Type, 2023-2024 (USD Thousand)
Figure 30 Average Selling Pricing Trend of Reagents, by Type, 2022-2024 (USD Thousand)
Figure 31 Average Selling Pricing Trend of Instruments, by Region, 2022-2024 (USD Thousand)
Figure 32 Hla Typing for Transplant Market: Porter's Five Forces Analysis
Figure 33 Influence of Key Stakeholders on Buying Process, by Product & Service
Figure 34 Key Buying Criteria for Major End-users
Figure 35 Hla Typing for Transplant Market: Trends/Disruptions I Mpacting Customers’ Businesses
Figure 36 Hla Typing for Transplant Market: Funding and Number of Deals, 2019-2023
Figure 37 Hla Typing for Transplant Market: Number of Deals, by Key Player, 2019-2023
Figure 38 Hla Typing for Transplant Market: Value of Deals, by Key Player, 2019-2023 (USD)
Figure 39 AI Use Cases in Hla Typing for Transplant Market
Figure 40 North America: Hla Typing for Transplant Market Snapshot
Figure 41 Asia-Pacific: Hla Typing for Transplant Market Snapshot
Figure 42 Revenue Analysis of Key Players in Hla Typing for Transplant Market (2020-2024)
Figure 43 Market Share Analysis of Players in Hla Typing for Transplant Market (2024)
Figure 44 Hla Typing for Transplant Market: Company Evaluation Matrix (Key Players), 2024
Figure 45 Hla Typing for Transplant Market: Company Footprint
Figure 46 Hla Typing for Transplant Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 47 EV/EBITDA of Key Vendors
Figure 48 5-Year Stock Beta of Key Vendors
Figure 49 Hla Typing for Transplant Market: Brand/Product Comparative Analysis
Figure 50 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 51 Illumina, Inc.: Company Snapshot
Figure 52 Qiagen: Company Snapshot
Figure 53 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 54 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 55 Caredx, Inc.: Company Snapshot
Figure 56 Diasorin S.P.A.: Company Snapshot
Figure 57 Becton, Dickinson and Company: Company Snapshot
Figure 58 Eurobio Scientific: Company Snapshot
Figure 59 Pacbio: Company Snapshot